Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.


Celldex Announces Webcast of EMERGE Data

May 21st 2012

Celldex Therapeutics will present the interim results of a phase IIb study testing the efficacy of a new monoclonal antibody in patients with advanced breast cancer.

Premature Aromatase Inhibitor Discontinuation Is Common

May 17th 2012

Roughly one-third of women with early-stage breast cancer develop intolerable adverse effects during aromatase inhibitor therapy.

Dr. Spector Discusses Breast Cancer Heterogeneity

May 14th 2012

Dr. Neil Spector, from Duke Cancer Institute, Explains Breast Cancer Heterogeneity

Is There a Best Adjuvant Chemotherapy Regimen for Breast Cancer?

May 11th 2012

Three prominent breast cancer clinicians and researchers share their opinions on adjuvant anthracyclines, fluoropyrimidines, and taxane agents for women with early breast cancer.

Leading Researcher Sees Turning Point in Breast Cancer: An Interview With José Baselga, MD, PhD

May 10th 2012

In a six-week span, José Baselga, MD, PhD, notched a stunning series of milestones in breast cancer research that could potentially change practice in different subtypes of the disease.

Dr. Ellis on Heterogeneity Impacting Biomarker Efficacy

May 9th 2012

Dr. Matthew Ellis, from Siteman Cancer Center, on Heterogeneity Impacting Biomarker Efficacy

Long-Term Breast Cancer Patient Follow-Up Care: Money Well Spent?

May 8th 2012

J. Michael Dixon, MBChB, MD, and Patrick I. Borgen, MD, discuss the pros and cons of long-term clinical follow-up care of patients with breast cancer.

Identifying Appropriate Patients for HER2-Targeted Therapies

May 6th 2012

Standards for identifying appropriate populations for treatment with HER2-targeted therapies are evolving.

Genetic Assessment of Breast and Ovarian Cancer Risk

April 30th 2012

Understanding the genetic basis of breast and ovarian cancers is essential to providing patients with effective preventive and/or management strategies that can improve outcomes.

Dr. Dixon Advises Against Mastectomies

April 26th 2012

Dr. J. Michael Dixon, from Western General Hospital, Scotland, Advises Against Mastectomies

Abandoning Old Paradigms: Embracing Molecular Targeting in Breast Cancer Treatments

April 26th 2012

A discussion with Pat Whitworth, Jr, MD, on how breast cancer treatment has evolved from a 'kitchen sink' approach with chemotherapy to a new paradigm that targets chemosensitivity.

Collaboration Across Disciplines Driving Progress in Breast Cancer: A Conversation With Debu Tripathy, MD

April 26th 2012

Debu Tripathy, MD, from the University of Southern California Norris Comprehensive Cancer Center, was one of four co-chairs of the 2012 Miami Breast Cancer Conference.

Landmark Study Redefines Breast Cancer Into 10 Subtypes

April 25th 2012

Researchers have determined that breast cancer can be classified into 10 different subtypes instead of four subtypes as previously thought.

Dr. Perez on the Mayo Clinic Breast Cancer Genomic Study

April 23rd 2012

Dr. Edith Perez, from the Mayo Clinic, Describes the Breast Cancer Translational Genomics Program

Bone Monitoring Is Essential With Exemestane Use for Primary Prevention of Breast Cancer

April 23rd 2012

Monitoring bone health and ensuring adequate calcium and vitamin D intake in postmenopausal women who are taking exemestane for the primary prevention of breast cancer is essential.

Dr. Jochelson on Breast Cancer Screening Techniques

April 19th 2012

Dr. Maxine Jochelson, from Memorial Sloan-Kettering Cancer Center, Discusses Complementary Breast Cancer Screening Techniques

Treatment Patterns of Metastatic Triple-Negative Breast Cancer in US Community Practice Settings

April 18th 2012

First-line treatment patterns for metastatic triple-negative breast cancer are diverse, reflecting a lack of consensus and an unmet need for standardized therapy.

Dr. Whitworth on Treating Breast Cancer With Chemo

April 17th 2012

Dr. Pat Whitworth, from the Vanderbilt University Medical Center, Discusses Chemotherapy for Breast Cancer

When Patients Refuse Treatment for Their Cancer

April 15th 2012

Quoting statistics seemed to be a refuge to me. The objectivity of the numbers provided a hiding place and a shelter, and they helped me maintain the emotional distance that my profession demanded.

Dr. Mamounas on Predicting the Risk of DCIS Recurrence

April 12th 2012

Dr. Eleftherios Mamounas, from Aultman Hospital Cancer Center, on Predicting the Risk of DCIS Recurrence

NEXT PAGE
PREVIOUS PAGE